Calls A, Torres-Espin A, Navarro X, Yuste VJ, Udina E, Bruna J.
Cisplatin-induced peripheral neuropathy is associated to neuronal senescence-like response.
Neuro-Oncology 2021, 23 (1): 88-99. IF: 13,029.
doi:10.1093/neuonc/noaa151.
Sánchez-Fernández A, Zandee S, Amo-Aparacio J, Charabati M, Prat A, Garlanda C, Eisenmesser EZ, Dinarello CA, López-Vales R.
IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.
Theranostics 2021, 11 (1): 1-13. IF: 11,600.
doi:10.7150/thno.47435.
Amo-Aparacio J, Sánchez-Fernández A, Li S, Eisenmesser EZ, Garlanda C, Dinarello CA, López-Vales R.
Extracellular and nuclear roles of IL-37 after spinal cord injury.
Brain Behav Immun 2021, 91: 194-201. IF: 19,227.
doi: 10.1016/j.bbi.2020.09.026.
Albu S, Kumru H, Coll R, Vives J, Vallés M, Benito-Penalva J, Rodríguez L, Codinach M, Hernández J, Navarro X, Vidal J.
Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study.
Cytotherapy 2021, 23 (2): 146-156. IF: 6,196.
doi: 10.1016/j.jcyt.2020.08.008.
Soler D, Moriña D, Kumru H, Vidal J, Navarro X.
Transcranial direct current stimulation and visual illusion effect according to sensory phenotypes in patients with spinal cord injury and neuropathic pain.
J Pain 2021, 22 (1): 86-89. IF: 5,383.
doi: 10.1016/j.jpain.2020.06.004.
Velasco R, Besora S, Argyriou AA, Santos C, Sala R, Izquierdo C, Simó M, Gil-Gil M, Pardo B, Jiménez L, Clapés V, Calvo M, Palmero R, Bruna J.
Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world, open-label experience.
Anti-Cancer Drugs 2021, 32 (1): 88-94. IF: 2,389.
doi: 10.1097/CAD.0000000000001005.
Alberti P, Bernasconi DP, Cornblath DR, Merkies ISJ, Park SB, Velasco R, Bruna J, Psimaras D, Koeppen S, Pace A, Dorsey SG, Argyriou AA, Kalofonos HP, Briani C, Schenone A, Faber CG, Mazzeo A, Grisold W, Valsecchi M, Cavaletti G.
Prospective evaluation of health care provider and patient assessments in chemotherapy-induced peripheral neurotoxicity.
Neurology 2021, 97 (7): e660-e672. IF: 12,258.
doi: 10.1212/WNL.0000000000012300.
Kumru H, Flores A, Rodríguez-Cañón M, Edgerton VR, Garcia L, Benito-Penalva J, Navarro X, Gerasimenko Y, García-Alías G, Vidal J.
Cervical electrical neuromodulation effectively enhances hand motor output in healthy subjects by engaging a use-dependent intervention.
J Clin Med 2021, 10 (2): 195. IF: 4,964.
doi: 10.3390/jcm10020195.
Sánchez-Ventura J, Giménez-Llort L, Penas C, Udina E.
Voluntary wheel running preserves lumbar perineuronal nets, enhances motor functions and prevents hyperreflexia after spinal cord injury.
Exp Neurol 2021, 336: 113533. IF: 5,620.
doi: 10.1016/j.expneurol.2020.113533.
Marmolejo-Martínez-Artesero S, Casas C, Romeo-Guitart D.
Endogenous mechanisms of neuroprotection: to boost or not to boost.
Cells 2021, 10 (2): 370. IF: 7,666.
doi: 10.3390/cells10020370.
Nieto-Nicolau N, López-Chicón P, Fariñas O, Bolívar S, Udina E, Navarro X, Casaroli-Marano RP, Vilarrodona A.
Effective decellularization of human nerve matrix for regenerative medicine with a novel protocol.
Cell Tissue Res 2021, 384(1):167-177. IF: 4,061.
doi: 10.1007/s00441-020-03317-3.
Herrando-Grabulosa M, Gaja-Capdevila N, Vela JM, Navarro X.
Sigma 1 receptor as a therapeutic target for amyotrophic lateral sclerosis.
Br J Pharmacol 2021, 178 (6): 1336–1352. IF: 9,473.
doi: 10.1111/bph.15224.
Ferrari LM, Rodríguez-Meana B, Bonisoli A, Cutrone A, Micera S, Navarro X, Greco F, Del Valle J.
All-polymer printed low-cost regenerative nerve cuff electrodes.
Front Bioeng Biotechnol 2021, 9: 615218. IF: 6,064.
doi: 10.3389/fbioe.2021.615218.
Puigdomenech-Poch M, Martínez-Muriana A, Andrés-Benito P, Ferrer I, Chun J, López-Vales R.
Dual role of lysophosphatidic acid receptor 2 (LPA2) in amyotrophic lateral sclerosis.
Front Cell Neurosci, 2021, 25: 15:600872. IF: 6,147.
doi:10.3389/FNCEL.2021.600873.
Mòdol-Caballero G, García-Lareu B, Herrando-Grabulosa M, Verdés S, López-Vales R, Pagès G, Chillón M, Navarro X, Bosch A.
Specific expression of Glial-Derived Neurotrophic Factor in muscles as gene therapy strategy for Amyotrophic Lateral Sclerosis.
Neurotherapeutics 2021, 18 (2): 1113–1126. IF: 6,088.
doi: 10.1007/s13311-021-01025-6.
Bonilla P, Hernández J, Giraldo E, González-Pérez MA, Alastrue-Agudo A, Elkhenany H, Vicent MJ, Navarro X, Edel M, Moreno-Manzano V.
Human-Induced neural and mesenchymal stem cell therapy combined with a curcumin nanoconjugate as a Spinal Cord Injury treatment.
Int J Mol Sci 2021, 22 (11): 5966. IF: 6,208.
doi: 10.3390/ijms22115966.
Hernández J, Francos-Quijorna I, Redondo-Castro E, López-Vales R, Navarro X.
Microglia stimulation by protein extract of injured rat spinal cord. A novel in vitro model for studying activated microglia.
Front Mol Neurosci 2021, 14: 582497. IF: 6,261.
doi: 10.3389/fnmol.2021.582497.
David S, López-Vales R.
Bioactive lipid mediators in the initiation and resolution of inflammation after spinal cord injury.
Neuroscience 2021, 466:273-297. IF: 3,708.
doi: 10.1016/j.neuroscience.2021.04.026.
Palomés-Borrajo G, Badia J, Navarro X, Penas C.
Nerve excitability and neuropathic pain is reduced by BET protein inhibition after spared nerve injury.
J Pain 2021, 22 (12): 1617-1630. IF: 5,383.
doi: 10.1016/j.jpain.2021.05.005.
Gaja-Capdevila N, Hernández N, Zamanillo D, Vela JM, Merlos M, Navarro X, Herrando-Grabulosa M.
Neuroprotective effects of Sigma 1 Receptor ligands on motoneuron death after spinal root injury in mice.
Int J Mol Sci 2021, 22 (13): 6956. IF: 6,208.
doi: 10.3390/ijms22136956.
del Valle J, Rodríguez-Meana B, Navarro X.
Neural electrodes for long-term tissue interfaces.
In Guçlu B (ed): “Somatosensory Feedback for Neuroprosthetics”, Elsevier, 2021, chapter 16: 509-536.
ISBN: 978-0-12-822828-9.
doi: 10.1016/B978-0-12-822828-9.00009-5.
Gras S, Blasco A, Mòdol-Caballero G, Tarabal O, Casanovas A, Piedrafita L, Barranco A, Das T, Rueda R, Pereira SL, Navarro X, Esquerda JE, Calderó J.
Beneficial effects of dietary supplementation with green tea catechins and cocoa flavanols on aging-related regressive changes in the mouse neuromuscular system.
Aging (Albany NY) 2021, 13 (14): 18051-18093. IF: 5,955.
doi: 10.18632/aging.203336.
Kumru H, Rodríguez-Cañón M, Edgerton VR, García L, Flores A, Soriano I, Opisso E, Gerasimenko Y, Navarro X, García-Alías G, Vidal J.
Transcutaneous electrical neuromodulation of the cervical spinal cord depends both on the stimulation intensity and the degree of voluntary activity for training. A pilot study.
J Clin Med 2021, 10 (15): 3278. IF: 4,964.
doi: 10.3390/jcm10153278.
Leiva-Rodríguez T, Romeo-Guitart D, Herrando-Grabulosa M, Muñoz-Guardiola P, Polo M, Bañuls C, Petegnief V, Bosch A, Lizcano JM, Apostolova N, Forés J, Casas C.
GRP78 overexpression triggers PINK1-IP3R-mediated neuroprotective mitophagy.
Biomedicines 2021, 9 (8): 1039. IF: 4,757.
doi: 10.3390/biomedicines9081039.
Amo-Aparicio J, Garcia-Garcia J, Francos-Quijorna I, Urpi A, Esteve-Codima A, Gut M, Quintana A, López-Vales R.
Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury.
Theranostics 2021, 11 (20): 9805-9820. IF: 11.600.
doi: 10.7150/thno.65203.
Sergi PN, De la Oliva N, del Valle J, Navarro X, Micera S.
Physically consistent scar tissue dynamics from scattered set of data: A novel computational approach to avoid the onset of the Runge phenomenon.
Applied Sciences 2021, 11 (18): 8568. IF: 2,838.
doi: 10.3390/app11188568.
Mòdol-Caballero G, Herrando-Grabulosa M, Verdés S, García-Lareu B, Hernández N, Francos-Quijorna I, López-Vales R, Bosch A, Navarro X.
Gene therapy overexpressing Neuregulin 1 type I in combination with Neuregulin 1 type III promotes functional improvement in the SOD1G93A ALS mice.
Front Neurol 2021, 12: 693309. IF: 4,086.
doi: 10.3389/fneur.2021.693309.
Velasco R, Villagrán M, Jové M, Simó M, Vilariño N, Alemany M, Palmero R, Martínez-Villacampa MM, Nadal E, Bruna J.
Encephalitis induced by immune checkpoint inhibitors: A systematic review.
JAMA Neurol 2021, 78 (7): 864-873. IF: 29,907.
doi: 10.1001/jamaneurol.2021.0249.
Velasco R, Domingo-Domenech E, Sureda A.
Brentuximab-induced peripheral neurotoxicity: A multidisciplinary approach to manage an emerging challenge in Hodgkin lymphoma therapy.
Cancers (Basel) 2021, 13 (23): 6125. IF: 6,575.
doi: 10.3390/cancers13236125.
Guiho T, López-Álvarez VM, Čvančara P, Hiairrassary A, Andreu D, Stieglitz T, Navarro X, Guiraud D.
New stimulation device to drive multiple transverse intrafascicular electrodes and achieve highly selective and rich neural responses.
Sensors 2021, 21 (21): 7219. IF: 3,847.
doi: 10.3390/s21217219.
Gaja-Capdevila N, Hernández N, Navarro X, Herrando-Grabulosa M.
Sigma-1 receptor is a pharmacological target to promote neuroprotection in the SOD1G93A ALS mice.
Front Pharmacol 2021, 12: 780588. IF: 5,988.
doi: 10.3389/fphar.2021.780588.
Flores A, López-Santos D, García-Alías G.
When spinal neuromodulation meets sensorimotor rehabilitation: lessons learned from animal models to regain manual dexterity after a spinal cord injury.
Front Rehabil Sci 2021, 2: 755963. IF: —.
doi: 10.3389/fresc.2021.755963.
Bruna J, Calls A, Yuste VJ.
Senescence in neurons: an open issue.
Aging-US (Albany NY) 2021, 13 (13): 16902-16903. IF: 5,955.
doi: 10.18632/aging.203329.
Velasco R, Alemany M, Villagrán M, Argyriou AA.
Predictive biomarkers of oxaliplatin-induced peripheral neurotoxicity.
J Pers Med 2021, 11 (7): 669. IF: 3,508.
doi: 10.3390/jpm11070669.